Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.210
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Arbutus Biopharma Employees
Arbutus Biopharma had 73 employees as of December 31, 2023. The number of employees decreased by 25 or -25.51% compared to the previous year.
Employees
73
Change (1Y)
-25
Growth (1Y)
-25.51%
Revenue / Employee
$92,356
Profits / Employee
-$1,050,685
Market Cap
608.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Varex Imaging | 2,400 |
Autolus Therapeutics | 471 |
Pharming Group | 382 |
Ironwood Pharmaceuticals | 267 |
Butterfly Network | 225 |
Omeros | 198 |
Entrada Therapeutics | 159 |
CARGO Therapeutics | 116 |
ABUS News
- 18 days ago - Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - Business Wire
- 25 days ago - Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - GlobeNewsWire
- 5 weeks ago - Arbutus' Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - GlobeNewsWire
- 5 weeks ago - Arbutus to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 2 months ago - Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024 - GlobeNewsWire
- 3 months ago - Arbutus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire